2,455 reports of this reaction
2.1% of all LEVETIRACETAM INJECTION reports
#6 most reported adverse reaction
FOETAL EXPOSURE DURING PREGNANCY is the #6 most commonly reported adverse reaction for LEVETIRACETAM INJECTION, manufactured by Dr.Reddy's Laboratories Inc. There are 2,455 FDA adverse event reports linking LEVETIRACETAM INJECTION to FOETAL EXPOSURE DURING PREGNANCY. This represents approximately 2.1% of all 117,357 adverse event reports for this drug.
Patients taking LEVETIRACETAM INJECTION who experience foetal exposure during pregnancy should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FOETAL EXPOSURE DURING PREGNANCY is a less commonly reported adverse event for LEVETIRACETAM INJECTION, but still significant enough to appear in the safety profile.
In addition to foetal exposure during pregnancy, the following adverse reactions have been reported for LEVETIRACETAM INJECTION:
The following drugs have also been linked to foetal exposure during pregnancy in FDA adverse event reports:
FOETAL EXPOSURE DURING PREGNANCY has been reported as an adverse event in 2,455 FDA reports for LEVETIRACETAM INJECTION. This does not prove causation, but indicates an association observed in post-market surveillance data.
FOETAL EXPOSURE DURING PREGNANCY accounts for approximately 2.1% of all adverse event reports for LEVETIRACETAM INJECTION, making it a notable side effect.
If you experience foetal exposure during pregnancy while taking LEVETIRACETAM INJECTION, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.